{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T19:31:53Z","timestamp":1769974313438,"version":"3.49.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,25]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Immunoglobulin G4-related disease (IgG4-RD) is a systemic rheumatic disease characterised by the infiltration of IgG4-positive plasma cells and swelling or hypertrophic lesions in various organs. IgG4-RD also involves optic lesions, which is known as IgG4-related ophthalmic disease (IgG4-ROD). IgG4-ROD involves the surrounding tissues, causing optic neuropathy when it affects the optic nerve. Impairment of the optic nerve is often progressive, with delayed diagnosis and treatment leading to permanent visual loss. However, optic neuropathy due to IgG4-RD is rare and the visual prognosis is unclear. Herein, we present a case of long-standing optic neuropathy in IgG4-ROD with loss of light perception.<\/jats:p>","DOI":"10.1093\/mrcr\/rxaf015","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T07:31:54Z","timestamp":1741159914000},"source":"Crossref","is-referenced-by-count":2,"title":["Successful glucocorticoid treatment case for IgG4-related long-standing optic neuropathy"],"prefix":"10.1093","volume":"9","author":[{"given":"Soma","family":"Fukami","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Seirei Hamamatsu General Hospital , Hamamatsu, Shizuoka,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8651-4149","authenticated-orcid":false,"given":"Shin-ichiro","family":"Ohmura","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Seirei Hamamatsu General Hospital , Hamamatsu, Shizuoka,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshitaka","family":"Yukishima","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Seirei Hamamatsu General Hospital , Hamamatsu, Shizuoka,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuto","family":"Hamada","sequence":"additional","affiliation":[{"name":"Department of Oculoplastic and Orbital Surgery, Seirei Hamamatsu General Hospital , Hamamatsu, Shizuoka,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Otsuki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Seirei Hamamatsu General Hospital , Hamamatsu, Shizuoka,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyoshi","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Division of Immunology and Rheumatology, Third Department of Internal Medicine, Hamamatsu University School of Medicine , Hamamatsu, Shizuoka,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"2025080201022081500_R1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"2025080201022081500_R2","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.3748\/wjg.14.3948","article-title":"IgG4-related sclerosing disease","volume":"14","author":"Kamisawa","year":"2008","journal-title":"World J Gastroenterol"},{"key":"2025080201022081500_R3","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/art.34593","article-title":"Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations","volume":"64","author":"Stone","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2025080201022081500_R4","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s40123-020-00313-2","article-title":"Immunoglobulin G4-related orbital disease with bilateral optic perineuritis and maxillary nerves involvement: a case report","volume":"9","author":"Hung","year":"2020","journal-title":"Ophthalmol Ther"},{"key":"2025080201022081500_R5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10384-024-01072-4","article-title":"The 2023 revised diagnostic criteria for IgG4-related ophthalmic disease","volume":"68","author":"Takahira","year":"2024","journal-title":"Jpn J Ophthalmol"},{"key":"2025080201022081500_R6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.41120","article-title":"The 2019 American College of Rheumatology\/European League against rheumatism classification criteria for IgG4-related disease","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2025080201022081500_R7","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-021-02210-z","article-title":"Ophthalmic involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 573 patients","volume":"21","author":"Gan","year":"2021","journal-title":"BMC Ophthalmol"},{"key":"2025080201022081500_R8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00417-013-2548-4","article-title":"Location and frequency of lesions in patients with IgG4-related ophthalmic diseases","volume":"252","author":"Sogabe","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2025080201022081500_R9","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00330-016-4481-5","article-title":"Infraorbital nerve involvement on magnetic resonance imaging in European patients with IgG4-related ophthalmic disease: a specific sign","volume":"27","author":"Soussan","year":"2017","journal-title":"Eur Radiol"},{"key":"2025080201022081500_R10","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006205","article-title":"Ophthalmic manifestations in IgG4-related disease: clinical presentation and response to treatment in a French case-series","volume":"96","author":"Ebbo","year":"2017","journal-title":"Medicine"},{"key":"2025080201022081500_R11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.rdc.2017.06.010","article-title":"Neurologic features of immunoglobulin G4-related disease","volume":"43","author":"AbdelRazek","year":"2017","journal-title":"Rheum Dis Clin North Am"},{"key":"2025080201022081500_R12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ophtha.2019.11.015","article-title":"Upper cranial nerve involvement and immunoglobulin G4-related optic neuropathy","volume":"127","author":"Lai","year":"2020","journal-title":"Ophthalmology"},{"key":"2025080201022081500_R13","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1097\/IOP.0b013e3182a64fa4","article-title":"Successful \u201cmedical\u201d orbital decompression with adjunctive rituximab for severe visual loss in IgG4-related orbital inflammatory disease with orbital myositis","volume":"30","author":"Chen","year":"2014","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"2025080201022081500_R14","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1093\/rheumatology\/keaa254","article-title":"Thoracic paravertebral involvement in patients with IgG4-related disease: CT and MR imaging findings","volume":"59","author":"Zhang","year":"2020","journal-title":"Rheumatology"},{"key":"2025080201022081500_R15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.13107\/jocr.2023.v13.i04.3606","article-title":"Mass: the conundrum in spine","volume":"13","author":"Rath","year":"2023","journal-title":"J Orthop Case Rep"},{"key":"2025080201022081500_R16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s12016-016-8584-1","article-title":"Idiopathic mediastinal fibrosis: a systemic immune-mediated disorder. A case series and a review of the literature","volume":"52","author":"Rossi","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"2025080201022081500_R17","article-title":"Thoracic paravertebral mass as an infrequent manifestation of IgG4-related disease","volume":"2017","author":"Matzumura Kuan","year":"2017","journal-title":"Case Rep Rheumatol"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxaf015\/62298462\/rxaf015.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/9\/2\/rxaf015\/62298462\/rxaf015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/9\/2\/rxaf015\/62298462\/rxaf015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T05:02:30Z","timestamp":1754110950000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/doi\/10.1093\/mrcr\/rxaf015\/8056117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,7,25]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxaf015","relation":{},"ISSN":["2472-5625"],"issn-type":[{"value":"2472-5625","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"rxaf015"}}